Meerut Reporter

Neuropathic Pain Market to Grow at a Substantial Growth Rate During the Forecast Period (2022-2032) – DelveInsight | Key Companies – Bayer, WEX Pharmaceuticals Inc, Lexicon Pharmaceuticals Inc

 Breaking News
  • No posts were found

Neuropathic Pain Market to Grow at a Substantial Growth Rate During the Forecast Period (2022-2032) – DelveInsight | Key Companies – Bayer, WEX Pharmaceuticals Inc, Lexicon Pharmaceuticals Inc

September 13
02:16 2022
Neuropathic Pain Market to Grow at a Substantial Growth Rate During the Forecast Period  (2022-2032) -  DelveInsight | Key Companies - Bayer, WEX Pharmaceuticals Inc, Lexicon Pharmaceuticals Inc
Halneuron, which is expected to launch during the forecast period (2022–2032), is believed to be the most successful therapy amongst all the other expected drug candidates and shall account for the highest market revenue in the coming years.

The Neuropathic Pain market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neuropathic Pain pipeline products will significantly revolutionize the Neuropathic Pain market dynamics.  

 

DelveInsight’s Neuropathic Pain Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of Neuropathic Pain, historical and forecasted epidemiology as well as the Neuropathic Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

 

Neuropathic Pain Overview

According to the International Association for the Study of Pain (IASP), neuropathic pain is defined as “pain initiated or caused by a primary lesion or dysfunction in the nervous system. Chronic neuropathic pain is common and may be related to an underlying health condition such as cancer or diabetic neuropathy, or it could be related to treatments such as chemotherapy.

Common causes of neuropathic pain include nerve pressure or nerve damage after surgery or trauma, viral infections, cancer, vascular malformations, alcoholism, neurological conditions such as multiple sclerosis, and metabolic conditions such as diabetes.

 

Neuropathic Pain Symptoms  

The Neuropathic Pain symptoms include –

  • Spontaneous pain
  • Burning, stabbing, and tingling feeling
  • Shooting
  • Stabbing pain 

 

Some of the key facts of the Neuropathic Pain Market Report: 

  • The Neuropathic Pain market size is anticipated to grow with a significant CAGR during the study period (2019-2032)  
  • According to Bouhassira D, the prevalence of neuropathic pain in the general population may be as high as 7 to 8%, accounting for 20 to 25% of individuals with chronic pain 
  • In a study by Pottathil S et.al, the incidence of chronic neuropathic pain is 10–14% in the United
  • Kingdom, 9.8–12.4% in the United States, and 7–10% worldwide 
  • Key Neuropathic Pain Companies: Bayer, WEX Pharmaceuticals Inc, Lexicon Pharmaceuticals Inc, and others
  • Key Neuropathic Pain Therapies: Halneuron, LX9211, BAY2395840, and others
  • The Neuropathic Pain epidemiology based on gender analyzed that Neuropathic Pain affects females more as compared to males
  • According to Cavalli E et.al neuropathic pain was more prevalent among women (60.5% of patients) and reached a peak at 50–64 years of age

 

Get a Free sample for the Neuropathic Pain Market Report 

 

Key benefits of the Neuropathic Pain Market report:

  1. Neuropathic Pain market report covers a descriptive overview and comprehensive insight of the Neuropathic Pain Epidemiology and Neuropathic Pain market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Neuropathic Pain market report provides insights on the current and emerging therapies.
  3. Neuropathic Pain market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Neuropathic Pain market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Neuropathic Pain market.

 

Discover more about therapies set to grab major Neuropathic Pain market share @ Neuropathic Pain market forecast 

 

Neuropathic Pain Epidemiology Segmentation:

The Neuropathic Pain market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Neuropathic Pain
  • Prevalent Cases of Neuropathic Pain by severity
  • Gender-specific Prevalence of Neuropathic Pain
  • Diagnosed Cases of Episodic and Chronic Neuropathic Pain 

 

Neuropathic Pain Market  

The dynamics of the Neuropathic Pain market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“The approval of novel therapies for the treatment of neuropathic pain has led to a major uptick in the DNP drugs market. 

For instance, in January 2022, US FDA approved the Senza Omnia spinal cord stimulation (SCS) system for chronic neuropathic pain treatment. Another drug, Tarlige (Mirogabalin besylate), was approved by PMDA Japan for Neuropathic Pain in 2022.”

 

Download the report to understand which factors are driving Neuropathic Pain epidemiology trends @ Neuropathic Pain Epidemiological Insights 

 

Neuropathic Pain Therapies

  • Halneuron
  • LX9211
  • BAY2395840

 

Neuropathic Pain Key Companies  

  • Bayer
  • WEX Pharmaceuticals Inc
  • Lexicon Pharmaceuticals Inc

 

Scope of the Neuropathic Pain Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Neuropathic Pain Companies: Bayer, WEX Pharmaceuticals Inc, Lexicon Pharmaceuticals Inc, and others
  • Key Neuropathic Pain Therapies: Halneuron, LX9211, BAY2395840, and others
  • Therapeutic Assessment: Neuropathic Pain current marketed and Neuropathic Pain emerging therapies
  • Neuropathic Pain Market Dynamics:  Neuropathic Pain market drivers and barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Neuropathic Pain  Market Access and Reimbursement 

 

Table of Contents 

1. Neuropathic Pain Market Report Introduction

2. Executive Summary for Neuropathic Pain

3. SWOT analysis of Neuropathic Pain

4. Neuropathic Pain Patient Share (%) Overview at a Glance

5. Neuropathic Pain Market Overview at a Glance

6. Neuropathic Pain Disease Background and Overview

7. Neuropathic Pain Epidemiology and Patient Population

8. Country-Specific Patient Population of Neuropathic Pain 

9. Neuropathic Pain Current Treatment and Medical Practices

10. Neuropathic Pain Unmet Needs

11. Neuropathic Pain Emerging Therapies

12. Neuropathic Pain Market Outlook

13. Country-Wise Neuropathic Pain Market Analysis (2019–2032)

14. Neuropathic Pain Market Access and Reimbursement of Therapies

15. Neuropathic Pain Market drivers

16. Neuropathic Pain Market barriers

17.  Neuropathic Pain Appendix

18. Neuropathic Pain Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Neuropathic Pain treatment, visit @ Neuropathic Pain Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/